To the Editor:
It is with considerable incredulity that, as an addiction professional, I view the activity of the Cannabis Task Force and its seemingly intractable position on approving retail outlets in Princeton. When one considers all the downsides of such a decision, given the knowledge we have about marijuana’s effect on the adolescent brain, the dramatic increase in pediatric emergencies in states that have legalized, increases in drugged driving cases, and a surge in black market activity in those “legalized” states, one can only assume that this task force has fallen, hook, line, and sinker for the marijuana industry’s aggressive marketing efforts to portray marijuana as a benign drug. Their campaign began by creating the myth of marijuana as a medicine and, while it may have beneficial effects for a small portion of the population, the marijuana lobby used this public health masquerade as a stepping-stone to its larger objective — mass commercialization of recreational marijuana. Make no mistake, the bottom line is the emergence and dominance of the marijuana industry by corporate entities and big tobacco companies. And this means, by definition, the need to expand markets and capture new customers. What better market than young people who are clearly the target of the promotion and use of candy-like THC edibles?
The industry has also created a false narrative around “social equity,” suggesting that dispensaries will compensate for past injustices to minorities. Yet, regarding minority access to the industry, nationally only 2 percent of cannabis businesses have minority ownership. Even so, what kind of “social equity” advocates for wider availability of a drug that has been proven to reduce cognition and blunt ambition and motivation? more